VSIG4, a marker highly specific to macrophages (15), is expressed in various cancers including lung (29), ovarian (30), pancreatic (31), thyroid (32), and high-grade glioma (19), where it is linked to tumor progression, poor prognosis, and immunosuppression. Here, VSIG4 is linked to central nervous system cancer.